Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 3 peer-reviewed journal articles Updated
Pediatric Neurology

Prognosis and the Path Ahead: Looking Toward the Future

At a Glance

Epilepsy with myoclonic absences has a highly variable outlook. Some children become seizure-free and develop typically, while others have seizures that remain difficult to control or face language and motor challenges; regular specialist follow-up and early support are important.

Thinking about your child’s future can be one of the most challenging parts of a diagnosis like Epilepsy with Myoclonic Absences (EMA). Because EMA is so rare, the information available is often based on small groups of patients, and every child’s path is unique. While some children do very well, others face a more complex journey requiring long-term support. Understanding the range of possibilities can help you prepare for the road ahead.

Will My Child Outgrow the Seizures?

The “remission rate”—the chance that seizures will stop entirely—is heterogeneous, meaning it varies significantly from one child to another depending on etiology, early treatment response, and seizure burden [1][2].

In small, retrospective clinical studies, researchers have found variable outcomes:

  • In one group of 11 children, about 45% (5 children) were seizure-free at their follow-up appointment [2].
  • In another group of 12 children, about 33% (4 children) remained seizure-free for at least one year [1].
  • However, many children—up to 50% to 60% in these small reports—continue to have seizures that are difficult to control with standard medications, a state known as drug-resistant epilepsy [2][3].

It is important to remember that these numbers come from very small, referral-biased cohorts. Being seizure-free at a follow-up appointment is not a guarantee of permanent remission. Your pediatric epileptologist is the best person to help you understand your child’s individual outlook.

Development and Learning

One of the biggest concerns for parents is how EMA will affect their child’s cognitive development. We know there is a strong link between the underlying cause of the epilepsy and how a child learns and grows.

  • Diverse Outcomes: Just as seizure control varies, so do developmental outcomes. Some children achieve seizure freedom and show neurotypical cognitive development [2].
  • The Role of Underlying Causes vs. Seizure Burden: In many small cohorts where children have developmental or language delays, these delays were present before the seizures even started [2]. This suggests that an underlying factor—such as a genetic variation—might be responsible for both the seizures and the learning challenges [2]. However, ongoing uncontrolled seizures, sleep disruption, and strong medication side effects can also severely impact daily functioning and learning.
  • Common Challenges: When delays do occur, they most frequently involve language development or motor skills [2]. Any sudden loss of previously acquired skills (regression) should prompt immediate clinical review.

How Seizures May Change Over Time

As children with EMA grow, the way their brain misfires can sometimes change. This is known as seizure evolution [1]. While myoclonic absences are the hallmark of the syndrome, some children may eventually experience other types of seizures, such as:

  • Generalized Tonic Seizures: Brief episodes of muscle stiffening [1].
  • Focal-Onset Impaired-Awareness Seizures: Seizures that appear to originate in one specific area of the brain rather than the whole brain [1].

If you notice new seizure patterns, it should prompt a repeat EEG and diagnostic review by your medical team to ensure treatments are still appropriately targeted.

Building a Support System

Regardless of the long-term prognosis, early and consistent support is one of the most effective ways to help your child reach their own specific goals and potential.

  • Early Intervention: If your child is under age three, early intervention services can provide vital support for speech, motor, and social development.
  • School Support: For school-aged children in the US, an Individualized Education Program (IEP) or a 504 Plan can ensure accommodations like extra time on tasks. Families in other countries should seek out equivalent formal special educational needs (SEN) or disability support frameworks in their school system.
  • Therapy Teams: Regular baseline assessments and sessions with speech-language pathologists or occupational therapists can address specific delays proactively [2].

The outlook for EMA requires careful monitoring because of the high rate of drug resistance in small cohorts [2]. By working closely with a specialized epilepsy team and putting supportive therapies in place early, you are giving your child the best possible foundation for their future quality of life.

Common questions in this guide

Can children with epilepsy with myoclonic absences become seizure-free?
Some children become seizure-free, but outcomes vary widely. Small studies reported that about one-third to nearly half of children were seizure-free at follow-up, while many had seizures that remained difficult to control. Being seizure-free at one visit does not guarantee permanent remission.
How might EMA affect my child’s learning and development?
Developmental outcomes range from typical development to language or motor delays. In some children, delays were present before seizures began, suggesting an underlying cause may affect both development and epilepsy. Uncontrolled seizures, disrupted sleep, and medication side effects can also interfere with learning and daily functioning.
Can seizure types change as a child with EMA grows?
Yes, some children may later develop generalized tonic seizures or focal-onset impaired-awareness seizures in addition to myoclonic absences. A new or changing seizure pattern should be reviewed by the medical team and may lead to a repeat EEG.
What support can help a child with EMA at school?
Children may benefit from early intervention, speech-language therapy, occupational therapy, and regular developmental assessments. School accommodations such as an Individualized Education Program or 504 Plan in the United States, or an equivalent support plan elsewhere, can address learning and functional needs.
What does drug-resistant epilepsy mean for a child with EMA?
Drug-resistant epilepsy means seizures remain difficult to control with standard anti-seizure medications. If seizures persist, the child’s epilepsy team may discuss options such as dietary therapy or other interventions based on the child’s individual needs.
What should parents track when assessing their child’s prognosis?
Keep track of seizure frequency, duration, appearance, and any new patterns, as well as changes in language, motor skills, learning, sleep, behavior, and medication side effects. Baseline developmental or neuropsychological assessments can help the care team measure changes over time.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Epilepsy with myoclonic absences.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my child's current seizure control and development, how would you describe their individual prognosis?
  2. 2.If my child's seizures are not fully controlled, what is the impact of seizures and medications on their cognitive development versus an underlying genetic cause?
  3. 3.What specific neuropsychological or developmental assessments should my child have to establish a baseline?
  4. 4.How do we monitor for the evolution of new seizure types, such as tonic or focal-onset seizures?
  5. 5.If seizures persist, at what point should we consider transitioning from medication to dietary therapy or other interventions to improve the long-term outlook?
  6. 6.Are there specific speech or motor milestones we should be tracking more closely given the common associations in EMA?

References

References (3)
  1. 1

    Epilepsy with myoclonic absences: Electroclinical characteristics in a distinctive pediatric epilepsy phenotype.

    Zanzmera P, Menon RN, Karkare K, et al.

    Epilepsy & behavior : E&B 2016; (64(Pt A)):242-247 doi:10.1016/j.yebeh.2016.08.023.

    PMID: 27770719
  2. 2

    Electroclinical features of myoclonic absence epilepsy: A single-center cohort analysis in Southwest China.

    Hu Q, Luo Y, Hong S, et al.

    Epilepsy & behavior : E&B 2025; (171()):110505 doi:10.1016/j.yebeh.2025.110505.

    PMID: 40414191
  3. 3

    Epilepsy with myoclonic absences: a case series highlighting clinical heterogeneity and surgical management.

    Carter EG, Armour EA, Pagano LM, Reddy SB

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(3)):541-547 doi:10.1684/epd.2022.1420.

    PMID: 35770757

This page explains possible long-term outcomes for children with epilepsy with myoclonic absences for informational purposes only and is not medical advice. Your child’s pediatric epileptologist and care team should interpret the prognosis and recommend individualized care.